Evidence map›Paper›PMID 36864230›Full record

ReviewWorld journal of microbiology & biotechnology2023

The two faces of pyocyanin - why and how to steer its production?

Joanna Jabłońska, Adrian Augustyniak, Kamila Dubrowska, Rafał Rakoczy

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in World journal of microbiology & biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Pigments from pathogenic bacteria: a comprehensive update on recent advances.World journal of microbiology & biotechnology · 2024
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Joanna JabłońskaFaculty of Chemical Technology and Engineering, Department of Chemical and Process Engineering, West Pomeranian University of Technology in Szczecin, al. Piastów 42, 71-065, Szczecin, Poland. joanna_jablonska@zut.edu.pl.
Adrian AugustyniakFaculty of Chemical Technology and Engineering, Department of Chemical and Process Engineering, West Pomeranian University of Technology in Szczecin, al. Piastów 42, 71-065, Szczecin, Poland.
Kamila DubrowskaFaculty of Chemical Technology and Engineering, Department of Chemical and Process Engineering, West Pomeranian University of Technology in Szczecin, al. Piastów 42, 71-065, Szczecin, Poland.
Rafał RakoczyFaculty of Chemical Technology and Engineering, Department of Chemical and Process Engineering, West Pomeranian University of Technology in Szczecin, al. Piastów 42, 71-065, Szczecin, Poland.
West Pomeranian University of Technology · PL

Funding

Narodowe Centrum Nauki 2021/41/N/ST8/01094
6 · The paper itself

Abstract

The ambiguous nature of pyocyanin was noted quite early after its discovery. This substance is a recognized Pseudomonas aeruginosa virulence factor that causes problems in cystic fibrosis, wound healing, and microbiologically induced corrosion. However, it can also be a potent chemical with potential use in a wide variety of technologies and applications, e.g. green energy production in microbial fuel cells, biocontrol in agriculture, therapy in medicine, or environmental protection. In this mini-review, we shortly describe the properties of pyocyanin, its role in the physiology of Pseudomonas and show the ever-growing interest in it. We also summarize the possible ways of modulating pyocyanin production. We underline different approaches of the researchers that aim either at lowering or increasing pyocyanin production by using different culturing methods, chemical additives, physical factors (e.g. electromagnetic field), or genetic engineering techniques. The review aims to present the ambiguous character of pyocyanin, underline its potential, and signalize the possible further research directions.

Indexed as

AgricultureCystic FibrosisCorrosionEngineeringGenetic EngineeringHumansPyocyaninePyocyanineBacterial pigmentBioprocessingPhenazinesPseudomonas aeruginosaSecondary metabolites

Identifiers

PMID36864230
PMCPMC9981528
OpenAlexW4322762142

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.